Showing 71-80 of 102 results for "".
Update on Approaches to Hair Restoration
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-approaches-to-hair-restoration/23317/From investigational JAK inhibitors to eyebrow transplants, here’s a look at the latest in hair restoration.Analysis of Gene Mutations by QIAGEN Clinical Insight (QCI) Interpretation Tool
https://practicaldermatology.com/youngmd-connect/resident-resource-center/analysis-of-gene-mutations-by-qiagen-clinical-insight-qciinterpretation-tool/23086/Currents
https://practicaldermatology.com/topics/practice-management/currents-5/23077/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-2/23000/Case Report: DRESS; NYU School of Medicine's Free Degree Initiative; Call for Cases
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-dress-nyu-school-of-medicines-free-degree-initiative-call-for-cases/20330/Exploring Hydrochlorothiazide Use and Skin Cancer Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/exploring-hydrochlorothiazide-use-and-skin-cancer-risk/20446/A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?Now What?
https://practicaldermatology.com/topics/psoriasis/now-what/20840/A look at what's now, what's next, and how dermatology practice continues to evolve with drugs, technologies, and opportunities.A History of Phlebology – Warts and All, Part 2 of 3
https://practicaldermatology.com/topics/general-topics/a-history-of-phlebology--warts-and-all-part-2-of-3/20862/Case Report, Plus Top Resident Presentations from CSF 2014, and Ask an Expert
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-plus-top-resident-presentations-from-csf-2014-and-ask-an-expert/21226/PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.